Rotavirus Reverse Genetics System to Study Viral Pathogenesis and Receptor Interactions
Rotavirus Reverse Genetics System to Study Viral Pathogenesis and Receptor Interactions
批准号:
10739026
负责人:
Linda J. Saif
金额:
$19.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-10 至 2025-06-30
关键词:
AcuteAddressAmino Acid SubstitutionAttenuatedBindingBiologicalBlood Group AntigensCell AdhesionCell Culture TechniquesCell-Matrix JunctionCellsCessation of lifeChildCholesterolClinicalDown-RegulationEpithelial CellsExcisionFamily suidaeGastroenteritisGene ExchangesGene Expression ProfileGenesGenetic TranscriptionGnotobioticGoalsHeterogeneityHumanHydrophobicityImmune signalingIn VitroIndividualInfectionIntestinesKnowledgeMetabolismModelingModificationMolecularMutationNatural ImmunityNeuraminidasePathogenesisPhenotypePhysiologicalPlasmidsPolysaccharidesPositioning AttributeProliferatingProtocols documentationRNARotavirusSequence AnalysisSeriesSeverity of illnessSialic AcidsSialyltransferasesSignal PathwaySmall IntestinesSourceSpecificitySystemTestingTherapeuticTransfectionTranslational ResearchVariantViral PathogenesisViral PhysiologyVirulenceVirulentVirusVirus ReceptorsZoonosesattenuationcomparativedesigndiarrheal diseasegenome analysisimprovedin vivoinnovationintestinal epitheliumjuvenile animalmortalitymutantnovelporcine modelreceptorrecombinant virusresponsereverse geneticstooltranscriptometransmission processvaccination strategyvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1 Abstract
2 Rotaviruses (RVs) of group A (RVAs) remain an important cause of acute gastroenteritis and mortality in young animals
3 and children. Despite their significance, mechanisms of RVA cell entry, replication and attenuation remain poorly
4 understood indicating a critical need to address these knowledge gaps and design universal control approaches.
5 We have previously conducted comparative sequence analysis that identified two key amino acid substitutions
6 associated with cell culture adaptation and attenuation: D385N in the VP4 of most human and porcine RVA strains and
7 D393H in porcine OSU strain VP4 only. While these or similar mutations were previously suggested to be important for
8 cell culture adaptation/attenuation, their function has not been confirmed experimentally. Using our porcine intestinal
9 enteroid (PIE) system, we have demonstrated that contrasting modes of interactions with the host glycans determine
10 replication efficacy of different RVA strains. OSU replication was uniquely and significantly down-regulated by the
11 removal of terminal sialic acids, while the latter significantly enhanced the replication of a novel porcine G9P[13] strain.
12 OSU is a historic dominant RVA variant characterized by robust in vivo and in vitro replication and consistently
13 associated with diarrheal disease in piglets for several decades, while G9P[13] and G9P[19] are recent, globally
14 emerging RVA variants in swine and humans. It is possible that the latter strains have evolved to acquire some biological
15 advantage allowing for their efficient spread and replication in different hosts. Virulent OSU and G9P[13] strains have
16 unique aa substitutions in the aa positions 385 and 393 of the VP4 hydrophobic loop, which could be a reason for
17 variable interactions with host glycans. Additionally, our recent study demonstrated that the host (PIE) transcriptome
18 response associated with OSU and G9P[13] infections differed drastically altering glycan expression, cholesterol
19 metabolism and innate immune signaling in a strain-specific manner. These findings suggest that evolutionary
20 adaptation of RVAs to the host and host glycans is a critical mechanism allowing for their interspecies (including
21 zoonotic) transmission.
22 Following a previously optimized protocol, our lab has successfully cloned 11 segments of virulent RVA OSU into the
23 pT7 plasmid and rescued infectious virus. We now propose to use this reverse genetics system for in-depth exploration
24 of the molecular mechanisms of RVA virulence, cell attachment and replication. The specific aims to achieve this goal
25 are summarized below:
26 Aim 1: Evaluate if the D385N and D393H substitutions (individually or in combination with other mutations in the OSU
27 VP4) introduced into OSU RGS (ic-virOSU) will confer an attenuated phenotype to the progeny virus (ic-attOSU). Aim
28 2: Evaluate if G9P[13]-like mutations (S385N and D393N) will confer the G9P[13]-like glycan specificity to the progeny
29 virus (ic-G9OSU). Aim 3: To conduct comparative transcriptome analysis of the wild-type (ic-virOSU) and mutant (OSU-
30 att and OSU-G9) OSU variants. Our PIE and Gn pig models as well as the newly established RGS will allow to study
31 how the identified VP4 mutations alter RVA virulence and the selective interactions with host glycans.
32
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Serologic and molecular determinants of COVID-19 severity and immune protection
-
批准号:10222411
-
项目类别:
-
资助金额:$81.82万
-
财政年份:2020
-
负责人:Linda J. Saif
-
依托单位:
Project 2: Serologic and molecular determinants of COVID-19 severity and immune protection
-
批准号:10688394
-
项目类别:
-
资助金额:$59.98万
-
财政年份:2020
-
负责人:Linda J. Saif
-
依托单位:
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
-
批准号:10427171
-
项目类别:
-
资助金额:$46.05万
-
财政年份:2018
-
负责人:Linda J. Saif
-
依托单位:
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
-
批准号:9759974
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2018
-
负责人:Linda J. Saif
-
依托单位:
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
-
批准号:9913564
-
项目类别:
-
资助金额:$46.99万
-
财政年份:2018
-
负责人:Linda J. Saif
-
依托单位:
Lactogenic immunity/probiotics: Effect on neonatal gut immunity
-
批准号:7656023
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:Linda J. Saif
-
依托单位:
Vitamin A adjuvant to enhance gut immunity and rotavirus vaccines in neonates
-
批准号:7880605
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2009
-
负责人:Linda J. Saif
-
依托单位:
Vitamin A adjuvant to enhance gut immunity and rotavirus vaccines in neonates
-
批准号:7706606
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2009
-
负责人:Linda J. Saif
-
依托单位:
Lactogenic immunity/probiotics: Effect on neonatal gut immunity
-
批准号:7841951
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2009
-
负责人:Linda J. Saif
-
依托单位:
Lactogenic immunity/probiotics: Effect on neonatal gut immunity
-
批准号:8090115
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2009
-
负责人:Linda J. Saif
-
依托单位:
Heterologous abs from llama and chicken egg yolk to prevent rotavirus diarrhea
-
批准号:7496304
-
项目类别:
-
资助金额:$3.97万
-
财政年份:2008
-
负责人:Linda J. Saif
-
依托单位:
Heterologous abs from llama and chicken egg yolk to prevent rotavirus diarrhea
-
批准号:7821277
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2008
-
负责人:Linda J. Saif
-
依托单位:
Heterologous abs from llama and chicken egg yolk to prevent rotavirus diarrhea
-
批准号:7669137
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2008
-
负责人:Linda J. Saif
-
依托单位:
Antigenic Relationships of SARS and Animal Coronaviruses
-
批准号:6849672
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2005
-
负责人:Linda J. Saif
-
依托单位:
Antigenic Relationships of SARS and Animal Coronaviruses
-
批准号:7090826
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2005
-
负责人:Linda J. Saif
-
依托单位:
Porcine Respiratory Coronavirus as a SARS Model
-
批准号:6806867
-
项目类别:
-
资助金额:$51.2万
-
财政年份:2004
-
负责人:Linda J. Saif
-
依托单位:
Porcine Respiratory Coronavirus as a SARS Model
-
批准号:7236026
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2004
-
负责人:Linda J. Saif
-
依托单位:
Porcine Respiratory Coronavirus as a SARS Model
-
批准号:6910846
-
项目类别:
-
资助金额:$47.5万
-
财政年份:2004
-
负责人:Linda J. Saif
-
依托单位:
Porcine Respiratory Coronavirus as a SARS Model
-
批准号:7088990
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2004
-
负责人:Linda J. Saif
-
依托单位:
PATHOGENESIS- HUMAN CALICIVIRUSES IN GNOTOBIOTIC ANIMALS
-
批准号:6374727
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2000
-
负责人:Linda J. Saif
-
依托单位:
海外基金